High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis.
about
Brain-skin connection: stress, inflammation and skin agingSphingosylphosphorylcholine in cancer progressAn update of the defensive barrier function of skinAntifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia speciesPotential Applications of Phyto-Derived Ceramides in Improving Epidermal Barrier Function.Skin barrier defects in atopic dermatitisMurine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis.Genotype analysis of Malassezia restricta as the major cutaneous flora in patients with atopic dermatitis and healthy subjects.Increased incidence of skin infections in atopy: evidence for an antigen-specific homing defect?Atopic dermatitis in children: clinical features, pathophysiology, and treatmentSkin as a route of exposure to protein allergens.Sequence diversity of the intergenic spacer region of the rRNA gene of Malassezia globosa colonizing the skin of patients with atopic dermatitis and healthy individuals.The impact of bioactive lipids on cardiovascular development.Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.The stratum corneum: structure and function in health and disease.Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Stratum corneum defensive functions: an integrated view.Atopic dermatitis prevention.The pH of the skin surface and its impact on the barrier function.Epidermal sphingolipids: metabolism, function, and roles in skin disorders.Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products.The Effect of Gromwell (Lithospermum erythrorhizon) Extract on the Stratum Corneum Hydration and Ceramides Content in Atopic Dermatitis PatientsAssociations among plasma vitamin C, epidermal ceramide and clinical severity of atopic dermatitisCeramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK.Glycosphingolipids--nature, function, and pharmacological modulation.Association between P478S polymorphism of the filaggrin gene & atopic dermatitis.Skin barrier in atopic dermatitis.Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.The stratum corneum: the rampart of the mammalian body.Barrier repair therapy in atopic dermatitis: an overview.Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin.Identification of candidate genes in atopic dermatitis based on bioinformatic methods.Treatment of Eczema: Corticosteroids and Beyond.Advancements in the maintenance of skin barrier/skin lipid composition and the involvement of metabolic enzymes.Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase.Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skinSphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.Sphingosylphosphorylcholine is a Melanogenic Stimulator for Human Melanocytes.
P2860
Q24563348-C8840516-2316-422B-92E3-CF5C65A8CA64Q26778510-8694225D-7167-44D5-8AE7-F98514714DDBQ28468651-F93692A1-CFBC-4AB6-9BCD-777310BE084DQ28769637-C4CD3510-2515-4D71-9A4D-D8FD3D372437Q30313257-E6B993EE-7901-4B65-9779-E1680B180889Q30405464-641F0AFE-784A-4C53-8737-E00257CF5BD8Q30494234-2D0CE644-B969-4EF8-B188-BFE4DC5FCDA2Q33629581-0206F9B3-FFCB-4360-9092-5F72D44675DEQ34361565-89E2CFE8-B53E-40E6-9376-39AD9183D147Q34585480-2639AAEF-A6B9-49FF-872D-EF6BCAB58384Q34625597-A5F966AB-AB24-48CD-B6BF-07BD36D1F36EQ34760559-1D5F7CEB-9916-46BE-8C10-8718D422F7ABQ35155594-4EE0908A-8BB7-4D41-88DB-DE945A69C923Q35173287-E3BF98C0-5BB7-422D-B88D-5C8742EDEC6DQ35561749-B5F1D349-82D8-4B33-9095-0DE95288A69EQ35631626-616CD701-EDC5-46C0-964C-F4B27C2A8604Q35688961-EEA74262-1C1E-48D2-949A-4CE837A3F810Q35838744-69F310FC-729D-4651-9426-4E19010E07C1Q36228049-9C6C528B-8320-4DE4-B722-6663F0935745Q36466794-A4A18327-BCDF-469F-8569-21BA666C73A4Q36545698-4F86FE3D-D2CD-4621-ADB2-8CEEEFDE3791Q36589543-F81F068B-26E6-4436-BBCD-232D7DEA9534Q36686119-4F1C5817-F0EE-41EE-B3AE-40799A0E3015Q36995806-A532099C-7EB2-42B9-AF90-85C5382D5DB9Q37121033-9CDC84D5-A7C2-4420-B715-8225EB38ABF3Q37323862-C06D6BD9-58F0-4D74-A077-EE15CB3D3BA3Q37622816-F7B9064F-E407-498D-93F6-F94E9637FB56Q37690846-6576B9FF-B6DC-415D-845F-BC4DFE268084Q37762460-C6BC0229-776D-4BF4-9D5B-E85DAC14926FQ37854092-B191623C-E3B3-4552-A41C-D8A33FDA3D89Q38075148-64433746-AAE9-46B5-AC22-AA4549409BA7Q38113741-747EF8F3-263F-44B1-88AE-1B92D7E0F4E4Q38168835-E0175EFB-E872-4F2A-BAE9-048818310ECFQ38293271-D7FCC2F9-65DA-43BA-9BA5-D5924F2BB3D6Q38419338-92838241-3A8F-4232-9895-BDBE8AF470FCQ38894252-65456292-4A3C-44F7-BF09-4C5D3E5BBF61Q41782077-F1E586A5-5DF6-4D89-9E95-E984BC730555Q41907249-631C6C0D-7443-4E31-BE49-BC2C1D13CE06Q44272174-AA79597D-189A-45C7-954D-F0D702097D17Q44663190-1CC03DF3-699A-4CD3-A40E-2F4BA572E29D
P2860
High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@ast
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@en
type
label
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@ast
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@en
prefLabel
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@ast
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@en
P2093
P921
P1476
High-expression of sphingomyel ...... sruption in atopic dermatitis.
@en
P2093
P304
P356
10.1046/J.1523-1747.2000.00072.X
P407
P577
2000-09-01T00:00:00Z
P5875
P6179
1040165681